These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18836331)

  • 21. Metabolic response of glioblastoma to superselective intra-arterial cerebral infusion of bevacizumab: a proton MR spectroscopic imaging study.
    Jeon JY; Kovanlikaya I; Boockvar JA; Mao X; Shin B; K Burkhardt J; Kesavabhotla K; Christos P; Riina H; Shungu DC; Tsiouris AJ
    AJNR Am J Neuroradiol; 2012 Dec; 33(11):2095-102. PubMed ID: 22576886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in anti-angiogenic therapy of cancer.
    Samant RS; Shevde LA
    Oncotarget; 2011 Mar; 2(3):122-34. PubMed ID: 21399234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gliomas in adults.
    Schneider T; Mawrin C; Scherlach C; Skalej M; Firsching R
    Dtsch Arztebl Int; 2010 Nov; 107(45):799-807; quiz 808. PubMed ID: 21124703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pro-migratory and pro-invasive role of the procoagulant tissue factor in malignant gliomas.
    Dützmann S; Gessler F; Harter PN; Gerlach R; Mittelbronn M; Seifert V; Kögel D
    Cell Adh Migr; 2010; 4(4):515-22. PubMed ID: 20595809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bevacizumab: in previously treated glioblastoma.
    Moen MD
    Drugs; 2010; 70(2):181-9. PubMed ID: 20108991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced imaging techniques in brain tumors.
    Law M
    Cancer Imaging; 2009 Oct; 9 Spec No A(Special issue A):S4-9. PubMed ID: 19965287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenetics of solid tumors: directed therapy in breast, lung, and colorectal cancer: a paper from the 2008 william beaumont hospital symposium on molecular pathology.
    Snozek CL; O'Kane DJ; Algeciras-Schimnich A
    J Mol Diagn; 2009 Sep; 11(5):381-9. PubMed ID: 19644023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic sagopilone (ZK-EPO) treatment of patients with recurrent malignant gliomas.
    Silvani A; Gaviani P; Fiumani A; Scaioli V; Lamperti E; Eoli M; Botturi A; Salmaggi A
    J Neurooncol; 2009 Oct; 95(1):61-64. PubMed ID: 19381446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bevacizumab and irinotecan in the treatment of recurrent malignant gliomas.
    de Groot JF; Yung WK
    Cancer J; 2008; 14(5):279-85. PubMed ID: 18836331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan.
    Zuniga RM; Torcuator R; Jain R; Anderson J; Doyle T; Ellika S; Schultz L; Mikkelsen T
    J Neurooncol; 2009 Feb; 91(3):329-36. PubMed ID: 18953493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What is the place of bevacizumab and irinotecan in the treatment of glioblastoma and other malignant gliomas?
    Omuro AM; Delattre JY
    Curr Opin Neurol; 2008 Dec; 21(6):717-9. PubMed ID: 18989118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiangiogenic therapy with bevacizumab in recurrent malignant gliomas: analysis of the response and core pathway aberrations.
    Zhang W; Qiu XG; Chen BS; Li SW; Cui Y; Ren H; Jiang T
    Chin Med J (Engl); 2009 Jun; 122(11):1250-4. PubMed ID: 19567132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging therapies for metastatic colorectal cancer: focus on EGFR and VEGF inhibition.
    Venook AP
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S74-84. PubMed ID: 19780248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bevacizumab: a treatment option for recurrent glioblastoma multiforme.
    Buie LW; Valgus J
    Ann Pharmacother; 2008 Oct; 42(10):1486-90. PubMed ID: 18765835
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.